Journal of Breast Imaging, Volume 5, Issue 3 Educational Review Article: "Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance"

Title of Activity: Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance

Date(s) of Activity: Launch Date: May 2, 2023 – Expiration Date: May 2, 2026

Educational/Learning Objectives: After completing this activity, the participant should be better able to:

1. Be aware of the recent changes of FDA guidelines for screening breast implants.
2. Review radiology appearance of implant rupture on US and MRI.
3. Increase awareness of other changes in FDA guidelines such as screening interval and patient's information card.

Statement of Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Michigan State Medical Society and the Society of Breast Imaging. The Michigan State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement: The MSMS designates this journal-based activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in this activity.